In literature, age of patients, performance status, IDH (isocitrate dehydrogenase) mutation, MGMT (O6 Methylguanine-DNA methyltransferase) methylation status, and treatment were commonly known as predictive factors for survival in glioblastoma. The gene discussed is IDH1; the disease is glioblastoma.